![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
LJ Marnett, PH Siedlik, RC Ochs, WR Pagels, M Das, KV Honn, RH Warnock, BE Tainer and TE Eling
Nafazatrom, an antithrombotic and antimetastatic agent containing a pyrazolone functionality, is a reducing substrate for the peroxidase activity of prostaglandin H (PGH) synthase. Nafazatrom inhibits the hydroperoxide-dependent oxidation of phenylbutazone, stimulates the reduction of 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid, and is oxidized by microsomal or purified enzyme preparations from ram seminal vesicles. Consonant with the effects of other peroxidase-reducing substrates, nafazatrom stimulates the oxygenation of arachidonic acid to prostaglandin endoperoxides by the cyclooxygenase component of PGH synthase. In addition, nafazatrom causes an elevation in the levels of 6-keto-prostaglandin F1 alpha, the non-enzymatic hydrolysis product of prostacyclin (PGI2) biosynthesized from arachidonic acid by ram seminal vesicle microsomes. Elevation of PGI2 biosynthetic capacity by nafazatrom occurs under conditions in which prostaglandin endoperoxide biosynthesis is maximal, suggesting that nafazatrom has a stimulatory effect on the conversion of prostaglandin endoperoxides to PGI2. Nafazatrom has no effect on the ability of ram seminal vesicle microsomes to convert PGH2 to PGI2 but protects microsomal PGI2 synthase from inactivation by 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid. Nafazatrom stimulates PGI2 biosynthesis in ram seminal vesicle microsomes by acting as a substrate for the peroxidase-catalyzed reduction of hydroperoxy fatty acids that are irreversible inactivators of PGI2 synthase. Several other compounds, including dipyridamole and triiodothyronine, exert similar effects. This may contribute to the reported ability of nafazatrom and related compounds to elevate the levels of bioassayable PGI2 in vivo and to the antithrombotic and antimetastatic activities of nafazatrom.
This article has been cited by other articles:
|
|
 |
|
  L. M. Szewczuk, L. Forti, L. A. Stivala, and T. M. Penning Resveratrol is a Peroxidase-mediated Inactivator of COX-1 but Not COX-2: A MECHANISTIC APPROACH TO THE DESIGN OF COX-1 SELECTIVE AGENTS J. Biol. Chem., May 21, 2004; 279(21): 22727 - 22737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Aronoff, O. Boutaud, L. J. Marnett, and J. A. Oates Inhibition of Prostaglandin H2 Synthases by Salicylate Is Dependent on the Oxidative State of the Enzymes J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 589 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Boutaud, D. M. Aronoff, J. H. Richardson, L. J. Marnett, and J. A. Oates Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases PNAS, May 14, 2002; 99(10): 7130 - 7135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Kalgutkar, B. C. Crews, S. W. Rowlinson, A. B. Marnett, K. R. Kozak, R. P. Remmel, and L. J. Marnett Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors PNAS, January 18, 2000; 97(2): 925 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Goodwin, M. R. Gunther, L. C. Hsi, B. C. Crews, T. E. Eling, R. P. Mason, and L. J. Marnett Nitric Oxide Trapping of Tyrosyl Radicals Generated during Prostaglandin Endoperoxide Synthase Turnover. DETECTION OF THE RADICAL DERIVATIVE OF TYROSINE 385 J. Biol. Chem., April 10, 1998; 273(15): 8903 - 8909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Koshkin and H. B. Dunford Reaction of Prostaglandin Endoperoxide Synthase with cis,cis-Eicosa-11,14-dienoic Acid J. Biol. Chem., March 13, 1998; 273(11): 6046 - 6049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Landino, B. C. Crews, J. K. Gierse, S. D. Hauser, and L. J. Marnett Mutational Analysis of the Role of the Distal Histidine and Glutamine Residues of Prostaglandin-Endoperoxide Synthase-2 in Peroxidase Catalysis, Hydroperoxide Reduction, and Cyclooxygenase Activation J. Biol. Chem., August 22, 1997; 272(34): 21565 - 21574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Landino, B. C. Crews, M. D. Timmons, J. D. Morrow, and L. J. Marnett Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis PNAS, December 24, 1996; 93(26): 15069 - 15074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bakovic and H. B. Dunford Reactions of Prostaglandin Endoperoxide Synthase and Its Compound I with Hydroperoxides J. Biol. Chem., January 26, 1996; 271(4): 2048 - 2056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. B. O'Donnell, B. Coles, M. J. Lewis, B. C. Crews, L. J. Marnett, and B. A. Freeman Catalytic Consumption of Nitric Oxide by Prostaglandin H Synthase-1 Regulates Platelet Function J. Biol. Chem., December 1, 2000; 275(49): 38239 - 38244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Kozak, S. W. Rowlinson, and L. J. Marnett Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2 J. Biol. Chem., October 20, 2000; 275(43): 33744 - 33749. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
